Intelligence Platform

Patents

Browse 259 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7901921

Viral purification methods

ONCOLYTICS BIOTECH INC. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7824697

High concentration baclofen preparations

The Board of Regents of the University of Texas System · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7815914

Methods for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803385

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7799329

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7781448

Once daily dosage forms of trospium

Supernus Pharmaceuticals, Inc. · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7771729

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant adm

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763252

Methods for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763635

Once daily dosage forms of trospium

Supernus Pharmaceuticals, Inc. · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759359

Method of treating bladder dysfunction with once-a-day trospium salt formulation

Supernus Pharmaceuticals, Inc. · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749532

Once daily formulations of tetracyclines

Supernus Pharmaceuticals, Inc. · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7731951

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7727534

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7708987

Methods for preventing reovirus recognition for the treatment of cellular proliferative di

ONCOLYTICS BIOTECH INC. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638550

Pyrrolic derivatives with histone deacetylase inhibitory activity

Universidad del Pais Vasco-Euskal Herriko Unibertsitatea (UPV-EHU) Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III (CNIO) · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608257

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7604944

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, n

Theravance, Inc. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585653

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, n

Theravance, Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582289

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7576065

Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concu

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7476382

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468426

Oncoprotein protein kinase antibody kit

The Regents of the University of California · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452723

Methods for preventing reovirus recognition for the treatment of cellular proliferative di

ONCOLYTICS BIOTECH INC. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7431932

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted